1-231019939-T-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_198552.3(FAM89A):āc.479A>Cā(p.Asp160Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000041 in 1,461,758 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_198552.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FAM89A | NM_198552.3 | c.479A>C | p.Asp160Ala | missense_variant | 2/2 | ENST00000366654.5 | NP_940954.1 | |
MIR1182 | NR_031593.1 | n.-15A>C | upstream_gene_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FAM89A | ENST00000366654.5 | c.479A>C | p.Asp160Ala | missense_variant | 2/2 | 1 | NM_198552.3 | ENSP00000355614.4 | ||
FAM89A | ENST00000466258.1 | n.462A>C | non_coding_transcript_exon_variant | 2/2 | 3 | |||||
FAM89A | ENST00000494111.1 | n.813A>C | non_coding_transcript_exon_variant | 3/3 | 5 | |||||
MIR1182 | ENST00000408363.1 | n.-15A>C | upstream_gene_variant | 6 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000410 AC: 6AN: 1461758Hom.: 0 Cov.: 31 AF XY: 0.00000550 AC XY: 4AN XY: 727208
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 15, 2024 | The c.479A>C (p.D160A) alteration is located in exon 2 (coding exon 2) of the FAM89A gene. This alteration results from a A to C substitution at nucleotide position 479, causing the aspartic acid (D) at amino acid position 160 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.